Calithera Biosciences Inc. (CALA)

3.88
NASDAQ : Health Technology
Prev Close 3.85
Day Low/High 3.79 / 3.93
52 Wk Low/High 3.43 / 6.90
Avg Volume 355.90K
Exchange NASDAQ
Shares Outstanding 53.77M
Market Cap 207.03M
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Calithera Biosciences Reports Second Quarter 2019 Financial Results And Recent Highlights

Calithera Biosciences Reports Second Quarter 2019 Financial Results And Recent Highlights

--Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.

Calithera Biosciences Initiates Phase 1/2 Trial Of Telaglenastat In Combination With Pfizer's CDK4/6 Inhibitor Palbociclib

Calithera Biosciences Initiates Phase 1/2 Trial Of Telaglenastat In Combination With Pfizer's CDK4/6 Inhibitor Palbociclib

Study is part of clinical trial collaboration with Pfizer

First Week Of August 16th Options Trading For Calithera Biosciences (CALA)

First Week Of August 16th Options Trading For Calithera Biosciences (CALA)

Investors in Calithera Biosciences, Inc. saw new options become available this week, for the August 16th expiration.

Calithera Biosciences Breaks Above 200-Day Moving Average - Bullish For CALA

Calithera Biosciences Breaks Above 200-Day Moving Average - Bullish For CALA

In trading on Thursday, shares of Calithera Biosciences, Inc. crossed above their 200 day moving average of $6.08, changing hands as high as $6.40 per share.

Calithera Biosciences Enters Oversold Territory (CALA)

Calithera Biosciences Enters Oversold Territory (CALA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADM, AFSI, CKX, EML, EVH, GDEN, MVC, MYGN, PANW, SO, SYKE, TARO Downgrades: IRCP, RMCF, UEIC, WYND Initiations: CALA, FG, MTNB Read on to get TheStreet Quant Ratings' detailed report:

Calithera Biosciences Reports Fourth Quarter 2017 Financial Results And Recent Highlights

Calithera Biosciences Reports Fourth Quarter 2017 Financial Results And Recent Highlights

-Calithera to Webcast Corporate Update on March 8, 2018

Commit To Purchase Calithera Biosciences At $5, Earn 27.5% Annualized Using Options

Commit To Purchase Calithera Biosciences At $5, Earn 27.5% Annualized Using Options

Investors considering a purchase of Calithera Biosciences, Inc. stock, but tentative about paying the going market price of $8.03/share, might benefit from considering selling puts among the alternative strategies at their disposal.

First Week of CALA April 20th Options Trading

First Week of CALA April 20th Options Trading

Investors in Calithera Biosciences, Inc. saw new options begin trading this week, for the April 20th expiration.

First Week of February 2018 Options Trading For Calithera Biosciences (CALA)

First Week of February 2018 Options Trading For Calithera Biosciences (CALA)

Investors in Calithera Biosciences, Inc. saw new options become available this week, for the February 2018 expiration.

Interesting CALA Put And Call Options For January 2018

Interesting CALA Put And Call Options For January 2018

Investors in Calithera Biosciences, Inc. saw new options become available this week, for the January 2018 expiration.

Oversold Conditions For Calithera Biosciences (CALA)

Oversold Conditions For Calithera Biosciences (CALA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Calithera Biosciences Stock Sees Short Interest Increase 10.6%

Calithera Biosciences Stock Sees Short Interest Increase 10.6%

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 278,209 share increase in total short interest for Calithera Biosciences, Inc. , to 2,910,428, an increase of 10.57% since 10/13/2017.

Calithera Biosciences Reports Third Quarter 2017 Financial Results And Recent Highlights

Calithera Biosciences Reports Third Quarter 2017 Financial Results And Recent Highlights

Calithera to Webcast Clinical Update on CB-839 on November 11, 2017